MSLN and pancreatic ductal adenocarcinoma: One illustrative example is the glycosylphosphatidylinositol-anchored cell-surface protein mesothelin (MSLN), whose expression is elevated in many pancreatic ductal adenocarcinoma (PDAC) cases1 and is associated with shorter overall survival2.